Adam Cooper
About Adam Cooper
Adam Cooper serves as the Vector Operations Manager at Adaptimmune, where he has worked since 2021. He previously held the position of Manufacturing Technologist at GlaxoSmithKline from 2013 to 2019.
Work at Adaptimmune
Adam Cooper has been employed at Adaptimmune since 2021, serving as the Vector Operations Manager for Cell and Gene Therapy (CGT). In this role, he oversees vector manufacturing processes, ensuring efficiency and compliance with industry standards. Prior to this position, he held the role of Vector Manufacturing Lead CGT at Adaptimmune starting in 2019. His responsibilities include managing manufacturing operations and leading teams to support the development of innovative therapies.
Previous Experience at GlaxoSmithKline
Before joining Adaptimmune, Adam Cooper worked at GlaxoSmithKline as a Manufacturing Technologist from 2013 to 2019. During his six years at the company, he gained extensive experience in manufacturing processes and quality control within the pharmaceutical industry. His role involved collaborating with cross-functional teams to enhance manufacturing efficiency and product quality.
Professional Background
Adam Cooper has built a career in the biotechnology and pharmaceutical sectors, focusing on vector manufacturing and operations management. His educational and professional experiences have equipped him with the skills necessary to manage complex manufacturing processes and lead teams effectively. His work primarily revolves around the development and production of cell and gene therapies.
Location and Industry
Adam Cooper is based in Stevenage, England, United Kingdom. He operates within the biotechnology industry, specifically in the field of cell and gene therapy. This sector is known for its innovative approaches to treating diseases through advanced manufacturing techniques and research.